Generic Drugs
22 articles on Generic Drugs, researched and written by the Shotlee Editorial Team from primary sources.
Ozempic Generics Recall: Why Cheap Semaglutide Copies Are Being Pulled
India's booming generic semaglutide market faces a credibility crisis as major manufacturers recall batches over quality concerns. Discover the implications for patient safety and treatment continuity.
9 min read
Ozempic, Mounjaro & More: Bridging the Global Gap for Cheaper Biologics
While generics have revolutionized drug affordability, newer biologics like those used for weight loss and diabetes face unique challenges. A new study reveals how varying international regulations are slowing the adoption of affordable biosimilars, impacting patient access and costs.
6 min read
Generic Ozempic® Now Available in Canada: What You Need to Know
Apotex Inc. has launched Apo-Semaglutide Injection™, a generic version of Ozempic®, in Canada. This development brings a more affordable treatment option for type 2 diabetes management to Canadian patients and healthcare providers.
6 min read
Wegovy Sales Surge 70% After Price Cuts: What You Need to Know
Novo Nordisk's Wegovy experienced a remarkable 70% sales volume increase in April after significant price adjustments. This development highlights the growing demand for GLP-1 receptor agonists in weight management and the dynamic shifts within the pharmaceutical market.
6 min read
Generic Semaglutide Approval in Canada: What It Means for Patients
Dr. Reddy's Laboratories has achieved a significant milestone by becoming the first company to receive market authorization from Health Canada for its generic semaglutide injection. This development promises to increase access to a crucial treatment option for Canadians.
6 min read
Generic GLP-1s: Hope for Affordable Weight Loss & Diabetes Care?
As brand-name GLP-1 medications such as Ozempic and Wegovy become increasingly sought after for weight loss and diabetes management, many Canadians face significant cost barriers. The anticipation surrounding the approval of generic semaglutide offers a beacon of hope for improved accessibility and affordability. This article delves into the current landscape, patient stories, and expert insights on the journey towards more accessible peptide therapies.
7 min read
Generic Ozempic Semaglutide Gets Tentative USFDA Approval; OneSource CDMO Par...
A generic version of Ozempic semaglutide has received tentative USFDA approval, marking a key step toward affordable GLP-1 therapy. Orbicular spearheaded product development, partnering with OneSource Specialty Pharma as the CDMO for reliable U.S. market manufacturing. This collaboration promises steady commercial supply from an FDA-approved site.
5 min read
Natco Pharma Starts Semaglutide Price War: Generic at ₹1,290/Month, 90% Cheaper
Natco Pharma is shaking up India's weight-loss drug market with its generic semaglutide priced at just ₹1,290 per month—90% cheaper than Novo Nordisk's Ozempic. Launching Saturday after patent expiry, this move invites competition from Sun Pharma, Dr Reddy's, and others. Patients gain affordable access to this GLP-1 powerhouse for weight management and diabetes.
5 min read
Low-Cost Semaglutide Generics Coming to India as Patent Expires
India's Semaglutide patent expires March 20, opening doors for low-cost generics from pharma giants like Zydus, Torrent, Sun Pharma, and Dr. Reddy's. With over 23% of women and 22% of men overweight per NFHS-5, and 45 crore adults projected obese by 2050, affordable options could reshape the fight against obesity and diabetes. Discover the price revolution and challenges ahead.
5 min read
Semaglutide Could Cost as Little as $28/Year by End of 2026
Semaglutide, the powerhouse behind Ozempic and Wegovy, might soon become dramatically more affordable. A recent study reveals generic versions could cost as little as $28 per person-year after patents expire in 2026. This could transform access to treatment for obesity and type 2 diabetes globally.
5 min read
Aspen Pharmacare Targets Semaglutide Generic Approval in Canada by September
Aspen Pharmacare Holdings Ltd. is aiming for regulatory approval of its copycat semaglutide version in Canada by September, positioning itself as a first-mover. CEO Stephen Saad shared this timeline in a recent interview, highlighting Canada's role as a benchmark for other nations. This development could enhance affordability of GLP-1 therapies like Ozempic.
5 min read
Ozempic-Like Drugs in India May Drop 50% in Price from March 2026
Semaglutide-based weight-loss drugs like Ozempic and Wegovy are set for a price revolution in India, with generics launching after patent expiry on March 20, 2026, potentially halving costs. Domestic giants like Sun Pharmaceutical and Dr. Reddy's are gearing up to make these GLP-1 therapies more affordable amid rising obesity rates. This shift could transform access to effective treatments for diabetes and weight management.
5 min read
Dr Reddy's Wegovy Generic Set for 50-60% Discounts in India
Indian drugmaker Dr Reddy's Laboratories is gearing up to launch a generic version of Novo Nordisk's Wegovy at prices up to 60% lower than the original. Co-chairman G V Prasad confirmed 50-60% discounts are feasible as semaglutide's patent nears expiry in March. This could reshape access to weight-loss treatments in India's competitive market.
5 min read
Knockoff GLP-1 Market Still the Wild West: Hims Fallout
Telehealth firm Hims & Hers sparked chaos by launching a cheap compounded Wegovy pill, only to yank it days later amid FDA crackdowns and a Novo Nordisk lawsuit. This incident highlights the ongoing Wild West in the knockoff GLP-1 market. Despite resolved shortages for Wegovy and Zepbound, unregulated compounded drugs remain widely available.
5 min read
Sun Pharma Approved for Generic Wegovy in India
Sun Pharmaceutical Industries secures approval to manufacture and sell generic Wegovy in India. The generic semaglutide, branded Noveltreat, launches after March 2026 patent expiry. Indian firms race to tap the booming GLP-1 weight loss market.
1 min read
Calgary Doctor Claims Generic Ozempic and Wegovy Drugs May Cut Costs by One-Third
According to a Calgary doctor, affordable generic alternatives to drugs like Ozempic and Wegovy might reduce expenses by up to a third. The content explores regional approaches to obesity management in Canada, emphasizing the challenges of rewiring brain circuitry and the role of medications in promoting healthier eating habits.
1 min read
Firms Will Be Able to Produce Generic Ozempic Starting Next Week, Yet Availability Remains Distant
Health Canada acknowledges public demand for cheaper generic options for the popular drug Ozempic. Several companies have filed for authorization, though timelines are unclear. Patients may face delays in accessing these alternatives.
1 min read
Are Replicas of Ozempic and Wegovy Safe? Understanding Compounded GLP-1s
Compounded semaglutide medications are custom-made by compounding pharmacies, containing the active ingredient in Ozempic and Wegovy. However, they are not FDA-approved and carry potential risks. This article explains what you need to know about these alternatives.
12 min read
Dr. Reddy's Cleared by Delhi HC to Export Semaglutide Generics of Novo Nordisk
An Indian court has granted Dr. Reddy's Laboratories Ltd permission to manufacture and export generic versions of Novo Nordisk's diabetes and obesity medications. This decision comes before the global patent expirations in 2026. The ruling allows export to countries without patent protection.
2 min read
Generic Drug Manufacturers Eye Price Adjustments as Novo Reduces Wegovy Costs
Following Novo Nordisk's price reduction for its Wegovy injection, generic drug manufacturers are reassessing their pricing strategies. The move comes amid increasing competition in the weight-loss drug market, with potential impacts on affordability and market share.
3 min read
Indian Drugmakers Adjust GLP-1 Pricing as Novo Nordisk Reduces Wegovy Cost in India
Indian drugmakers are modifying their pricing strategies for weight-loss injections after Novo Nordisk decreased the price of Wegovy. Generic companies are now reassessing their launch prices due to this shift. Competition is anticipated to lower prices in the GLP-1 market.
3 min read
Chinese Pharmaceutical Sector on the Verge of Global Expansion
China's pharmaceutical industry is rapidly ascending on the global stage, fueled by innovation and strategic alliances with Western companies. This rise presents both opportunities and challenges as China aims to become a major player in drug discovery and development.
7 min read